Valneva SE (VALN) Interest Coverage Ratio (2021 - 2026)
Valneva SE (VALN) posted Interest Coverage Ratio of 4.65 for Q1 2026, up 507.18% sequentially from 1.14 in Q4 2025, and up 366.84% YoY from 1.0 in Q1 2025.
Powered by 
Analysis
Valneva SE (VALN) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Valneva SE has reported Interest Coverage Ratio for 6 years, with the latest figure at 4.65 in Q1 2026.
- Quarterly Interest Coverage Ratio rose 366.84% year-over-year to 4.65 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.32 (up 8.22% YoY) and the FY2025 annual result came in at 1.96, down 452.61% from the prior year.
- Interest Coverage Ratio improved to 4.65 in Q1 2026 per VALN's latest filing, from 1.14 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 37.92 in Q2 2022 and troughed at 17.96 in Q3 2022.
- A 5-year average of 0.79 and a median of 0.78 in 2023 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2022 and 2024: Interest Coverage Ratio soared 914.84% in 2022, then tumbled 52268.87% in 2024.
- Over 5 years, Interest Coverage Ratio stood at 1.74 in 2022, then soared by 55.3% to 0.78 in 2023, then tumbled by 327.08% to 3.31 in 2024, then surged by 65.52% to 1.14 in 2025, then surged by 507.18% to 4.65 in 2026.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 4.65, 1.14, and 1.28 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn | 5.04 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.04 |
| Mar 31, 2026 | 4.65 |
| Dec 31, 2025 | -1.14 |
| Sep 30, 2025 | -1.28 |
| Jun 30, 2025 | 1.94 |
| Mar 31, 2025 | 1.00 |
| Dec 31, 2024 | -3.31 |
| Sep 30, 2024 | -0.42 |
| Jun 30, 2024 | 4.36 |
| Mar 31, 2024 | -9.68 |
| Dec 31, 2023 | 2.30 |
| Sep 30, 2023 | 6.17 |
| Jun 30, 2023 | 4.86 |
| Mar 31, 2023 | 3.25 |
| Dec 31, 2022 | 9.96 |
| Sep 30, 2022 | -17.96 |
| Jun 30, 2022 | 37.92 |
| Mar 31, 2022 | 3.90 |
| Dec 31, 2021 | -36.51 |
| Sep 30, 2021 | 40.86 |